The DOI matches its Crossref record; 336 of the 336 references it cites were found in a registry or an index.
Improving translation of animal models of addiction and relapse by reverse translation
Abstract
Critical features of human addiction are increasingly being incorporated into complementary animal models, including escalation of drug intake, punished drug seeking and taking, intermittent drug access, choice between drug and non-drug rewards, and assessment of individual differences based on criteria in the fourth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Combined with new technologies, these models advanced our understanding of brain mechanisms of drug self-administration and relapse, but these mechanistic gains have not led to improvements in addiction treatment. This problem is not unique to addiction neuroscience, but it is an increasing source of disappointment and calls to regroup. Here we first summarize behavioural and neurobiological results from the animal models mentioned above. We then propose a reverse translational approach, whose goal is to develop models that mimic successful treatments: opioid agonist maintenance, contingency management and the community-reinforcement approach. These reverse-translated 'treatments' may provide an ecologically relevant platform from which to discover new circuits, test new medications and improve translation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the abuse potential of (S) and in particular (R)-ketamine appears to be much lower than anticipated, especially compared to stimulants and opioids like cocaine and morphine (Venniro et al., 2020).”
From Mechanisms of ketamine and its metabolites as antidepressants (2022) · cites this paper as Venniro et al., 2020
Citations
Cites
Drug abuse: hedonic homeostatic dysregulation
Koob, G. F., & Moal, M. L. (1997) · Science · doi:10.1126/science.278.5335.52 · Cited by 2,535
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002207.pub4 · Cited by 2,274
Animal models of neuropsychiatric disorders
Nestler, E. J., & Hyman, S. E. (2010) · Nature Neuroscience · doi:10.1038/nn.2647 · Cited by 2,023
The reinstatement model of drug relapse: history, methodology and major findings
Shaham, Y., Shalev, U., Lu, L., de Wit, H., & Stewart, J. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1224-x · Cited by 1,615
Self-citationAddiction Is a Brain Disease, and It Matters
Leshner, A. I. (1997) · Science · doi:10.1126/science.278.5335.45 · Cited by 1,615
Anthony, J. C., Warner, L. A., & Kessler, R. C. (1994) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.2.3.244 · Cited by 1,341
Molecular and Cellular Basis of Addiction
Nestler, E. J., & Aghajanian, G. K. (1997) · Science · doi:10.1126/science.278.5335.58 · Cited by 1,313
Pharmacological interventions for smoking cessation: an overview and network meta-analysis
Cahill, K., Stevens, S., Perera, R., & Lancaster, T. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009329.pub2 · Cited by 1,243
Dole, V. P. (1965) · JAMA · doi:10.1001/jama.1965.03090080008002 · Cited by 1,240
Cited by
Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability
Bonaventura, J., Lam, S., Carlton, M., Boehm, M. A., Gomez, J. L., Solís, O., Sánchez-Soto, M., Morris, P. J., Fredriksson, I., Thomas, C. J., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01093-2 · Cited by 271
Self-citationMechanisms of ketamine and its metabolites as antidepressants
Hess, E. M., Riggs, L. M., Michaelides, M., & Gould, T. D. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114892 · Cited by 175
A neuromarker for drug and food craving distinguishes drug users from non-users
Koban, L., Wager, T. D., & Hedy Kober, A. (2022) · Nature Neuroscience · doi:10.1038/s41593-022-01228-w · Cited by 165
Sex Differences in Opioid and Psychostimulant Craving and Relapse: A Critical Review
Nicolas, C., Zlebnik, N. E., Farokhnia, M., Leggio, L., Ikemoto, S., & Shaham, Y. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000367 · Cited by 165
Self-citationAnimal Models of Drug Relapse and Craving after Voluntary Abstinence: A Review
Fredriksson, I., Vènniro, M., Reiner, D. J., Chow, J. J., Bossert, J. M., & Shaham, Y. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000191 · Cited by 115
Self-citation
Metadata
- Authors
- Venniro, M., Banks, M. L., Heilig, M., Epstein, D. H., & Shaham, Y.
- Affiliations
- Virginia Commonwealth University (US)
- Linköping University (SE)
- National Institute on Drug Abuse (US)
- National Institutes of Health (US)
- Corresponding author
- Shaham, Yavin
- Venue
- Nature Reviews Neuroscience
- Published
- 2020-10-06
- Volume
- 21
- Issue
- 11
- Pages
- 625-643
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- OpenAlex
- W3092055061
- Cited by
- 212
- References
- 335
- Citations by year
- 2026: 27 · 2025: 43 · 2024: 41 · 2023: 28 · 2022: 38 · 2021: 32 · 2020: 2
- FWCI
- 3.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Drug Abuse (UG3DA050311, R00DA047976, UH3DA041146, R01DA026946)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Keywords
- animal models of addiction, relapse, reverse translation, translational research, self-administration, drug-seeking behavior, reward choice, individual differences, contingency management, community reinforcement, addiction treatment
- MeSH terms
- Analgesics, Opioid, Animals, Brain, Disease Models, Animal, Recurrence, Reinforcement, Psychology, Reward, Substance-Related Disorders, Translational Research, Biomedical, Drug-Seeking Behavior
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Improving translation of animal models of addiction and relapse by reverse translation. https://app.cochat.ai/papers/10.1038/s41583-020-0378-z
- The paper
- Venniro, M., Banks, M. L., Heilig, M., Epstein, D. H., & Shaham, Y. (2020). Improving translation of animal models of addiction and relapse by reverse translation. Nature Reviews Neuroscience. https://doi.org/10.1038/s41583-020-0378-z
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.